|
1) Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003; 349: 1315-23
|
|
|
|
2) Stone GW, Ellis SG, Cox DA, et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med. 2004; 350: 221-31
|
|
|
|
|
|
3) McFadden EP, Stabile E, Regar E, et al. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet. 2004; 364: 1519-21
|
|
|
|
|
|
4) Pfisterer M, Brunner-La Rocca HP, Buser PT, et al. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents. J Am Coll Cardiol. 2006; 48: 2584-91
|
|
|
|
|
|
5) Camenzind E, Steg G, William Wijns. Stent thrombosis late after implantation of first-generation drug-eluting stents: A Cause for Concern. Circulation. 2007; 115: 1440-55
|
|
|
|
|
|
6) Nordman A, Briel M, Bucher HC. Mortality in randomized controlled trials comparing drug-eluting vs bare metal stents in coronary artery disease: a metaanalysis. Eur Heart J. 2006; 27: 2784-814
|
|
|
|
|
|
7) Lagerqvist B, James SK, Stenestrand U, et al. Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N Engl J Med. 2007; 356: 1009-19
|
|
|
|
|
|
8) Stone GW, Moses JW, Ellis SG, et al. Safety and efficacy of sirolimus-and paclitaxel-eluting coronary Stents. N Engl J Med. 2007; 356: 998-1008
|
|
|
|
|
|
9) Daeman J, Wenaweser P, Tsuchida K, et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet. 2007; 369: 667-78
|
|
|
|
|
|
10) Mauri L, Hsieh W, Massaro JM, et al. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med. 2007; 356: 1020-9
|
|
|
|
|
|
11) Kastrati A, Mehilli J, Pache J, et al. Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med. 2007; 356: 1030-9
|
|
|
|
|
|
12) Urban P, Gershlick AH, Guagliumi G, et al. Safety of coronary sirolimus-eluting stents in daily clinical practice: one-year follow-up of the e-Cypher registry. Circulation. 2006; 113: 1434-41
|
|
|
|
|
|
13) Schomig A, Dibra A, Windecker S, et al. A meta-analysis of 16 randomized trials of sirolimus-eluting stents versas paclitaxel-eluting stens in patients with coronary artery disease. J Am Coll Cardiol. 2007; 50: 1373-80
|
|
|
|
|
|
14) Williams DO, Abbott JD, Kip KE, et al. Outcomes of 6906 patients undergoing percutaneous coronary intervention in the era of drugeluting stents: report of the DEScover registry. Circulation. 2006; 114: 2154-62
|
|
|
|
|
|
15) Waksman R, Buch AN, Torguson R, et al. Long-term clinical outcomes and thrombosis rates of sirolimus-eluting versus paclitaxel-eluting stents in an unselected population with coronary artery disease (REWARDS registry). Am J Cardiol. 2007; 100: 45-51
|
|
|
|
|
|
16) Cosgrave J, Meizi G, Corbett S, et al. Comparable clinical outcomes with paclitaxel- and sirolimus-eluting stents in unselected contemporary practice. J Am Coll Cardiol. 2007; 49: 2320-8
|
|
|
|
|
|
17) LeLorier J, Gregoire G, Benhaddad B, et al. Discrepancies between meta-analysis and subsequent large randomized controlled trials. N Engl J Med. 1997; 337: 536-42
|
|
|
|
|